Finasteride nano-transferosomal gel formula for management of androgenetic alopecia: ex vivo investigational approach

References

• BrennerSMatzHImprovement in androgenetic alopecia in 53–76-year-old men using oral finasterideInt J Dermatol1999381292893010632776
   PubMed Web of Science ®Google Scholar
• HoffmannRFinasteride is the main inhibitor of 5α-reductase activity in microdissected dermal papillae of human hair folliclesArch Dermatol Res19992912–310010310195397
   PubMed Web of Science ®Google Scholar
• WhitingDAdvances in the treatment of male androgenetic alopecia: a brief review of finasteride studiesEur J Dermatology2001114332334
   PubMed Web of Science ®Google Scholar
• KaufmanKFinasteride, 1 mg (Propecia), is the optimal dose for the treatment of men with male pattern hair lossArch Dermatol1999135898999010456354
   PubMed Web of Science ®Google Scholar
• D’AmicoARoehrbornCEffect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trialLancet Oncol200781212517196507
   PubMed Web of Science ®Google Scholar
• PriceVMenefeeESanchezMChanges in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three-and 4-year resultsJ Am Acad Dermatol2006551717416781295
   PubMed Web of Science ®Google Scholar
• RathnayakeDSinclairRMale androgenetic alopeciaExpert Opin Pharmacother20101181295130420426708
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationDrug Approval Package Proscar (Finasteride) Tablets Available from: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/020180_s027_ProscarTOC.cfmAccessed December 14, 2017
   Google Scholar
• HirshburgJMKelseyPATherrienCAGavinoACReichenbergJSAdverse effects and safety of 5-alpha reductase inhibitors (finasteride, dutasteride): a systematic reviewJ Clin Aesthet Dermatol2016975662
   PubMedGoogle Scholar
• Carreño-OrellanaNMoll-ManzurCCarrasco-ZuberJEÁlvarez-VélizSBerroeta-MaurizianoDPorras-KusmanicNEfectos adversos de finasteride: mitos y realidades. Una revisión actualizada [Finasteride adverse effects: An update]Rev Med Chil20161441215841590 Spanish28393993
   PubMed Web of Science ®Google Scholar
• CarusoDAbbiatiFGiattiSPatients treated for male pattern hair with finasteride show, after discontinuation of the drug, altered levels of neuroactive steroids in cerebrospinal fluid and plasmaJ steroid Biochem Mol Biol2015146747924717976
   PubMed Web of Science ®Google Scholar
• AhmedOAAAfounaMIEl-SayKMAbdel-NaimABKhedrABanjarZMOptimization of self-nanoemulsifying systems for the enhancement of in vivo hypoglycemic efficacy of glimepiride transdermal patchesExpert Opin Drug Deliv20141171005101324702435
   PubMed Web of Science ®Google Scholar
• CaonTPortoLGranadaAChitosan-decorated polystyrene-b-poly (acrylic acid) polymersomes as novel carriers for topical delivery of finasterideEur J Pharm Sci20145216517224262075
   PubMed Web of Science ®Google Scholar
• CaseriniMRadicioniMLeurattiCAnnoniOPalmieriRA novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteersInt J Clin Pharmacol Ther2014521084284925074865
   PubMed Web of Science ®Google Scholar
• MaestrelliFGonzález-RodríguezMEffect of preparation technique on the properties of liposomes encapsulating ketoprofen–cyclodextrin complexes aimed for transdermal deliveryInt J Pharm20063121–2536016469460
   PubMed Web of Science ®Google Scholar
• MezeiMGulasekharamVLiposomes – a selective drug delivery system for the topical route of administration. Lotion dosage formLife Sci19802618147314776893068
   PubMed Web of Science ®Google Scholar
• MezeiMGulasekharamVLiposomes – a selective drug delivery system for the topical route of administration: gel dosage formJ Pharm Pharmacol19823474734746126554
   PubMed Web of Science ®Google Scholar
• RajanRJoseSMukundVTransferosomes-A vesicular transdermal delivery system for enhanced drug permeationJ Adv Pharm Technol Res20112313814322171309
   PubMedGoogle Scholar
• Badr-EldinSMAhmedOAAOptimized nano-transfersomal films for enhanced sildenafil citrate transdermal delivery: ex vivo and in vivo evaluationDrug Des Devel Ther20161013231333
   PubMed Web of Science ®Google Scholar
• CevcGBlumeGNew, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, TransfersomesBiochim Biophys Acta20011514219120511557020
   PubMed Web of Science ®Google Scholar
• BensonHATransfersomes for transdermal drug deliveryExpert Opin Drug Deliv20063672773717076595
   PubMedGoogle Scholar
• BragagniMMenniniNMaestrelliFCirriMMuraPComparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxibDrug Deliv201219735436123043648
   PubMed Web of Science ®Google Scholar
• MahmoodSTaherMMandalUExperimental design and optimization of raloxifene hydrochloride loaded nanotransfersomes for transdermal applicationInt J Nanomedicine201494331434625246789
   PubMed Web of Science ®Google Scholar
• ChoiMMaibachHElastic vesicles as topical/transdermal drug delivery systemsInt J Cosmet Sci200527421122118492190
   PubMedGoogle Scholar
• NtimenouVFahrAElastic vesicles for transdermal drug delivery of hydrophilic drugs: a comparison of important physicochemical characteristics of different vesicle typesJ Biomed Nanotechnol20128461362322852471
   PubMed Web of Science ®Google Scholar
• El-NabarawiMBendasEEl RehemRAMYTransdermal drug delivery of paroxetine through lipid-vesicular formulation to augment its bioavailabilityInt J Pharm20134431–230731723337629
   PubMed Web of Science ®Google Scholar
• ShammaRNElsayedITransfersomal lyophilized gel of buspirone HCl: formulation, evaluation and statistical optimizationJ Liposome Res201323324425423713516
   PubMed Web of Science ®Google Scholar
• AhmedOAHusseinAKMadyFMOptimisation of microstructured biodegradable finasteride formulation for depot parenteral applicationJ Microencapsul201633322923826886073
   PubMed Web of Science ®Google Scholar
• AhmedOAAAhmedTAAbdel-NaimABKhedrABanjarZMAfounaMIEnhancement of in vitro skin transport and in vivo hypoglycemic efficacy of glimepiride transdermal patchesTrop J Pharm Res201413812071213
   Web of Science ®Google Scholar
• HiguchiTMechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matricesJ Pharm Sci196352121145114914088963
   PubMed Web of Science ®Google Scholar
• CostaPSousa LoboJMModeling and comparison of dissolution profilesEur J Pharm Sci200113212313311297896
   PubMed Web of Science ®Google Scholar
• El ZaafaranyGGMAwadGGASHolayelSSMMortadaNDNRole of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin deliveryInt J Pharm20103971–216417220599487
   PubMed Web of Science ®Google Scholar
• BensonHElastic liposomes for topical and transdermal drug deliveryCurr Drug Deliv20096321722619604135
   PubMedGoogle Scholar